Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Bioanalysis|October 24, 2017
Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspectiveUlrich Kunz, Joanne Goodman, Ulf Loevgren, et al.
Bioanalysis|March 17, 2021
A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis ForumAnna Laurén, Joanne Goodman, Jonas Blaes, et al.
Bioanalysis|August 5, 2024
A European Bioanalysis Forum recommendation for requiring a context-of-use statement for successful development and validation of biomarker assaysKyra J Cowan, Ulrich Kunz, Peter Blattmann, et al.
International Journal of Pharmaceutics|January 9, 2020
Developing an injectable co-formulation of two antidiabetic drugs: Excipient impact on peptide aggregation and pharmacokinetic propertiesAnne-Laure Lainé, Sophie Houvenagel, Anders Broo, et al.
Frontiers in Immunology|May 2, 2022
SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)Richard Stebbings, Christopher Jones, Peter Cotton, et al.
Bioanalysis|October 4, 2021
Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein-MS from the 2021 European Bioanalysis Forum Focus WorkshopsPhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Bioanalysis|January 27, 2023
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guidelinePhilip Timmerman, Matthew Barfield, Kyra Cowan, et al.
Bioanalysis|January 19, 2018
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdlesJoanne Goodman, Simon Cowen, Viswanath Devanarayan, et al.
Bioanalysis|August 5, 2024
The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assaysKyra J Cowan, Lysie Champion, Daniel Dyer, et al.
Journal of the American Heart Association|January 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 ResultsAndrea L Vavere, Marvin Sinsakul, Emily L Ongstad, et al.
Pageof 3